Clinical Trial Update: Respiratory Microbiome in COPD and Associated Inmune Response.

View source ↗

Summary

An update on a clinical trial studying the respiratory microbiome in chronic obstructive pulmonary disease and the associated immune response.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Pulmonary Disease (COPD), Chronic Obstructive | Status: UNKNOWN